Gestational Diabetes Mellitus: Insulin or Oral Hypoglycemic Agents?

Trial Profile

Gestational Diabetes Mellitus: Insulin or Oral Hypoglycemic Agents?

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jul 2016

At a glance

  • Drugs Insulin (Primary) ; Glibenclamide; Metformin
  • Indications Gestational diabetes
  • Focus Therapeutic Use
  • Acronyms DG5
  • Most Recent Events

    • 04 Jan 2016 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 16 Jun 2015 Planned End Date changed from 1 Apr 2015 to 1 Jun 2015 as per ClinicalTrials.gov record..
    • 14 May 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top